Exoxemis Exoxemis - Indications
Home Technology Indications Collaborations Company Publications Contact
Nosocosmial Infections Surgical Site Infection Biodefence
 
>

Nosocomial Infections

Multiple MPO formulations are in development for prevention of serious, and often resistant, hospital-acquired infections.
more >>

 
       
>

Surgical Site Infection Prevention

Our unique MPO formulation holds the promise of a breakthrough in surgical site infection prevention.
more >>

   
       
>

Biodefense

The MPO technology platform suggests the potential for use in preventing infections in conventional and biological attack situations.

   
       
>
E-mail Inquiries    

Biodefense

Biodefense is a public health imperative where timely medical countermeasures are needed to improve survival and minimize morbidity in disaster situations.

The sporicidal, bactericidal, and viricidal activity of MPO and EPO, combined with stability and portability, suggest the potential for multiple uses in preventing infections in conventional and biological attack, and other catastrophic situations.

A recent study by Exoxemis suggests that the MPO system may be useful in the prevention of anthrax and other infections caused by biowarfare agents. In vitro exposure of vegetative and spore forms of Bacillus species to the MPO enzyme system showed 100% kill of Bacillus spores within within 120 minutes. more >>


Product platform for easy portability and administration

Our technologies provide a platform for the development of products that include wound treatments, skin protectants and decontaminants, and respiratory agents. MPO enzyme formulations are active in gel, spray, ointment, and solution formulations that can be packaged for easy portability and on-site administration.